Proteomic Analysis of Aortae from Human Lipoprotein(a) Transgenic Mice Shows an Early Metabolic Response Independent of Atherosclerosis

作者: Euan J Rodger , Rachel J Suetani , Gregory T Jones , Torsten Kleffmann , Alan Carne

DOI: 10.1371/JOURNAL.PONE.0030383

关键词: High-density lipoproteinGenetically modified mouseImmunologyLipoproteinLipid metabolismBiologyDownregulation and upregulationLipoprotein(a)Internal medicineEndocrinologyCholesterolGel electrophoresisGeneral Biochemistry, Genetics and Molecular BiologyGeneral Agricultural and Biological SciencesGeneral Medicine

摘要: Background: Elevated low density lipoprotein (LDL) and lipoprotein(a) are independent risk factors for the development of atherosclerosis. Using a proteomic approach we aimed to determine early changes in arterial protein expression transgenic mice containing both human LDL circulation. Methods Results: Plasma lipid analyses showed had significantly higher levels than wildtype, including much increased high (HDL) cholesterol. Analysis aortae from accumulation but no or foam cells, leaving arteries essentially atherosclerosis free. two-dimensional gel electrophoresis mass spectrometry, identified 34 proteins with altered abundance (P<0.05) compared wildtype 17 that ≥2 fold difference. Some interest similarly at transcript level. These collectively indicated an initial metabolic response included down regulation energy, redox metabolism structural stage when not yet developed. Conclusions: Our study shows promote unique set which may be indicators disturbances preceding

参考文章(39)
G Chiesa, H.H. Hobbs, M.L. Koschinsky, R.M. Lawn, S.D. Maika, R.E. Hammer, Reconstitution of lipoprotein(a) by infusion of human low density lipoprotein into transgenic mice expressing human apolipoprotein(a). Journal of Biological Chemistry. ,vol. 267, pp. 24369- 24374 ,(1992) , 10.1016/S0021-9258(18)35775-2
Liza Makowski, Jeffrey B. Boord, Kazuhisa Maeda, Vladimir R. Babaev, K. Teoman Uysal, Maureen A. Morgan, Rex A. Parker, Jill Suttles, Sergio Fazio, Gökhan S. Hotamisligil, MacRae F. Linton, Lack of macrophage fatty-acid–binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis Nature Medicine. ,vol. 7, pp. 699- 705 ,(2001) , 10.1038/89076
S M Marcovina, J J Albers, B Gabel, M L Koschinsky, V P Gaur, Effect of the number of apolipoprotein(a) kringle 4 domains on immunochemical measurements of lipoprotein(a). Clinical Chemistry. ,vol. 41, pp. 246- 255 ,(1995) , 10.1093/CLINCHEM/41.2.246
Thierry Rabilloud, Cécile Lelong, Mireille Chevallet, Sylvie Luche, Two-dimensional gel electrophoresis in proteomics: Past, present and future. Journal of Proteomics. ,vol. 73, pp. 2064- 2077 ,(2010) , 10.1016/J.JPROT.2010.05.016
G Utermann, The mysteries of lipoprotein(a) Science. ,vol. 246, pp. 904- 910 ,(1989) , 10.1126/SCIENCE.2530631
M F Linton, R V Farese, G Chiesa, D S Grass, P Chin, R E Hammer, H H Hobbs, S G Young, Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a). Journal of Clinical Investigation. ,vol. 92, pp. 3029- 3037 ,(1993) , 10.1172/JCI116927
Pia R. Kamstrup, Marianne Benn, Anne Tybjærg-Hansen, Børge G. Nordestgaard, Extreme Lipoprotein(a) Levels and Risk of Myocardial Infarction in the General Population. The Copenhagen City Heart Study Circulation. ,vol. 117, pp. 176- 184 ,(2008) , 10.1161/CIRCULATIONAHA.107.715698
Ulrich Förstermann, Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies Nature Clinical Practice Cardiovascular Medicine. ,vol. 5, pp. 338- 349 ,(2008) , 10.1038/NCPCARDIO1211
M. J. Callow, L. J. Stoltzfus, R. M. Lawn, E. M. Rubin, Expression of human apolipoprotein B and assembly of lipoprotein(a) in transgenic mice Proceedings of the National Academy of Sciences of the United States of America. ,vol. 91, pp. 2130- 2134 ,(1994) , 10.1073/PNAS.91.6.2130
Sotirios Tsimikas, Joseph L Witztum, The role of oxidized phospholipids in mediating lipoprotein(a) atherogenicity. Current Opinion in Lipidology. ,vol. 19, pp. 369- 377 ,(2008) , 10.1097/MOL.0B013E328308B622